Related Experiment Video
Updated: Jun 13, 2026
08:07
Equine Enteric Glial Culture and Application to the Study of a Neural Inflammatory Mechanism in Equine Colic
Published on: October 4, 2024
Do horses suffer from irritable bowel syndrome?
1Gastroenterology Research Unit, Addenbrooke's Hospital, Cambridge, UK.
Equine Veterinary Journal
|April 14, 2010
Summary
Irritable Bowel Syndrome (IBS) in humans shares similarities with colic and laminitis in horses, potentially caused by gut microflora imbalances. Metabolomic studies may help identify horses at risk for these conditions.
Area of Science:
- Veterinary Medicine
- Gastroenterology
- Microbiome Research
Background:
- Irritable Bowel Syndrome (IBS) in humans has diverse causes, with a common form resembling colic and laminitis in horses.
- Malabsorption of food residues into the colon can lead to bacterial fermentation and disease, with severe consequences in horses but less harm in healthy humans.
Purpose of the Study:
- To investigate potential similarities in colonic microflora imbalances between human IBS and equine colic/laminitis.
- To explore the utility of metabolomic studies in identifying gut changes in horses susceptible to colic and laminitis.
Main Methods:
- Comparison of human IBS pathophysiology with equine colic and laminitis.
- Hypothesizing subtle changes in equine gut microflora following events like gastroenteritis or antibiotic treatment.
- Proposing metabolomic analysis of urine and feces as a method to detect these changes.
Main Results:
- The abstract does not contain specific results, but outlines a research direction.
Conclusions:
- Metabolomic studies offer a promising approach to identify gut microflora changes in horses.
- This research could lead to better risk identification and improved treatments for equine colic and laminitis.
Related Concept Videos
01:23Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.